Introduction
The ability to identify and express emotions through facial expression is an essential component of human communication and social interaction. The manifestation of a facial expression consequent to an emotion is a complex process that involves functions different from those involved in voluntary movement of facial muscles.temporal gyrus, amygdale, ventral striatum, hippocampus, and dorsomedial nucleus of the thalamus. 4, 5 Moreover, it is known that the right hemisphere is more involved in the expression of emotion than the left. [6] [7] [8] The Facial Action Coding System (FACS) of Ekman and Friesen 9 is one of the most widely used instruments in the analysis of facial expression. It is based on an anatomical analysis of facial action through the codification of facial expression into 44 "action units." Action units are anatomically defined, and represent the basic repertoire of human facial expressions. Using FACS, the intensity and variety of facial movements can be observed objectively. It has been repeatedly reported that psychiatric patients and especially patients with schizophrenia show characteristic facial activities, [10] [11] [12] [13] [14] [15] such as reduced levels of facial expressivity compared with healthy controls in reaction to emotional stimuli, [16] [17] [18] during social interactions, 19 and/or as a result of the effects of medication. 20 Several studies have evaluated the facial expression of patients with schizophrenia in response to appropriate emotive stimuli using the FACS as a rating system of the emotions expressed, reporting that treatment with neuroleptics induces a deficit in the recognition and expression of emotions, 21 mainly related to the upper face, 16 and to specific emotions such as amusement, pain, anger, fear, and disgust. 22 Further, it was found that reduction in facial expressions in response to emotive stimuli was correlated with the presence of negative symptoms, in particular with affective flattening 7, 23 and that there was no effect of gender with regard to facial expression in schizophrenia. 24 Just one study evaluated facial expressiveness in patients with obsessive-compulsive disorder using FACS; Mergl et al 25 found that execution of adequate facial reactions to humor was abnormally slow in patients with obsessive-compulsive disorder and correlated with severity of symptoms.
Use of video clips to elicit specific emotions has a long history in clinical psychology and psychiatry; 26 Gross and Levenson systematized this issue, selecting and validating 16 films that successfully elicited amusement, anger, contentment, disgust, sadness, surprise, fear, and a neutral state. 27 Several studies using movie clips to elicit emotions in patients with schizophrenia have reported a diminished emotional response in comparison with healthy controls, 13 and just one study investigated this issue in patients with obsessive-compulsive disorder. 25 Obsessive-compulsive disorder and schizophrenia are considered to have common neurodevelopmental origins, and comorbidity between these two disorders is quite frequent. 28 The objective of this study was to evaluate emotivity, expressed through facial expression, in patients with schizophrenia and obsessive-compulsive disorder in relation to specific emotional stimuli. We hypothesize that both diseases may present with significantly impaired perception and expression of emotions in comparison with healthy controls, suggesting an additional common pathological element between schizophrenia and obsessive-compulsive disorder.
Materials and methods Participants
The sample consisted of outpatients recruited at the A Fiorini Hospital of Terracina, Sapienza University of Rome, and healthy controls. After signing an written informed consent form, patients underwent a structured clinical interview according to the SCID-I model 29 and the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. They were then divided in two groups, ie, patients suffering from obsessive-compulsive disorder (n = 10) and those suffering from schizophrenia (n = 10, Table 1 ). Patients with significant neurological diseases, other Axis 1 diagnoses, tardive dyskinesia, a history of abuse of alcohol or other drugs of abuse, or on treatment with typical antipsychotics were excluded from the study.
Study design
The first stage of this study required participants to be assessed using the following scales: Brief Psychiatric Rating Scale 24-items (BPRS) for all patients, the YaleBrown Obsessive Compulsive Scale (Y-BOCS) for patients with obsessive-compulsive disorder, and the Positive and Negative Syndrome Scale (PANSS) for patients with schizophrenia. The BPRS is a rating scale used to measure psychiatric symptoms. Each symptom is rated 1-7 and the following items are scored: somatic concern, anxiety, depression, suicidality, guilt, hostility, elevated mood, grandiosity, suspiciousness, hallucinations, unusual thought content, bizarre behavior, self-neglect, disorientation, conceptual disorganization, affective flattening, emotional withdrawal, motor retardation, tension, uncooperativeness, excitement, distractibility, motor hyperactivity, and mannerisms and posturing. 30 The Y-BOCS is a test to rate the severity of symptoms of obsessive-compulsive disorder. The scale is a clinicianrated, 10-item scale (obsession-free interval, interference submit your manuscript | www.dovepress.com Dovepress Dovepress due to obsessive thoughts, distress associated with obsessive thoughts, resistance against obsessions, degree of control over obsessive thoughts, time spent performing compulsive behaviors, interference due to compulsive behaviors, distress associated with compulsive behavior, resistance against compulsions, degree of control over compulsive behavior), each item rated from 0 (no symptoms) to 4 (extreme symptoms), yielding a total possible score range from 0 to 40.
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The PANSS is a scale used to assess the severity of symptoms among patients with schizophrenia. Administration takes approximately 45 minutes and patients are rated from 1 to 7 on 30 different symptoms subdivided into three subscales: positive (delusions, conceptual disorganization, hallucinations, hyperactivity, grandiosity, suspiciousness/ persecution, hostility); negative (blunted affect, emotional withdrawal, poor rapport, passive/apathetic social withdrawal, difficulty in abstract thinking, lack of spontaneity and flow of conversation, stereotyped thinking); and general psychopathology (somatic concern, anxiety, guilt feelings, tension, mannerisms and posturing, depression, motor retardation, uncooperativeness, unusual thought content, disorientation, poor attention, lack of judgment and insight, disturbance of volition, poor impulse control, preoccupation, active social avoidance). 32 In a second phase (film session), all patients watched video clips designed to elicit significant and specific emotions, including amusement, fear, surprise, anger, sadness, disgust, or neutrality. The mimic reaction of each patient in response to the vision of the films was video-recorded. These video clips, all in Italian, were watched by the three groups of people in the same order, according to the protocol of Gross and Levenson: 27 video 1, neutral; video 2, amusement; video 3, fear; video 4, surprise; video 5, anger; video 6, sadness; video 7, disgust; and video 8, amusement (Table 2 ). Between video clips, patients were asked to fill out a post film questionnaire to indicate the emotion experienced in relation to the video (Table 3) . Each response to the questionnaire was then scored in relation to the expected emotion.
Two different reports were produced. In the report of concordant responses, a score of 1 was given for each emotional report concordant with the expected emotion, and a score 0 was given if the patient reported not having felt any emotion (neutrality) or having felt an emotion different from that expected. Scores could range between a minimum of 0 and a maximum of 8. In the report of discordant responses, a score of 1 was given for each emotional report discordant with the expected emotion associated with the video clip and 0 if the patient reported not having felt any emotion (neutrality). Scores could range between a minimum of 0 and a maximum of 8.
At the end of the film session, the mimic reactions to the video clips were coded following the indications in the FACS investigator's guide. 33 The same three examiners (EP, GV, DL) evaluated all the video registrations. The three examiners previously attended a specific three-day workshop organized by the FACS Research Center at the University of Trieste. The scoring took into account the specific emotion associated with the video expected 27 and the combination of action units observed in response. Because each video was evocative of only one specific emotion, 27 specific combinations of action units were expected in relation to each video. 33 If one of the expected combinations of emotion and action units occurred, the examiners assigned a score of 1; if the expected combinations did not occur, the examiners assigned a score of 0 (this scoring was repeated for each movie clip).
Statistical analysis
The data were analyzed using Statistical Package for the Social Sciences (SPSS Inc, Chicago, IL) software version 17. Means, standard deviations, and Pearson's correlation coefficient were used. One-way univariate analysis of variance was performed to compare the means of patients divided into diagnosis groups. Because the diagnosis factor had more than two levels, post hoc tests were calculated using the Bonferroni test.
Results

Demographics
Ten patients were enrolled in each of the three groups of participants: obsessive-compulsive disorder group (mean age 40.22 ± 13.49 years), schizophrenia group (mean age 40.88 ± 12.97 years), and healthy participants (mean age 40.20 ± 10.49 years). Each group included five males and five females (Table 1) . At the time of evaluation, obsessive-compulsive disorder patients were treated with the following medications: clomipramine (n = 7), fluvoxamine (n = 4), sertraline (n = 1), escitalopram (n = 1), citalopram (n = 1), valproic acid (n = 3), gabapentin (n = 1), alprazolam (n = 3), lorazepam (n = 1), and zolpidem (n = 1). Schizophrenia patients were treated with the following medications: paliperidone (n = 3), aripiprazole (n = 4), olanzapine (n = 1), quetiapine (n = 1), clozapine submit your manuscript | www.dovepress.com Dovepress Dovepress (n = 1), risperidone (n = 1), valproic acid (n = 4), and lithium (n = 1).
Post film questionnaire: concordant and discordant responses
In the report of concordant responses, analysis of variance showed that the diagnosis factor influenced the total score of concordant responses in the post film questionnaire (F[2.25] = 16.413; P # 0.001).
Comparing the groups between them with the post hoc Bonferroni test, our results showed that healthy controls had significantly higher scores (7.60 ± 0.516) than both obsessive-compulsive disorder patients (5.11 ± 1.833; difference of means −2.489; P = 0.004) and schizophrenia patients (3.78 ± 1.787; difference of means −3.822; P , 0.001). There was no difference in performance between patients with obsessive-compulsive disorder and those with schizophrenia ( Figure 1 ).
In the report of discordant responses, analysis of variance showed that the diagnosis factor influenced the total score of discordant responses in the post film questionnaire (F[2.25] = 9.205; P = 0.001). Post hoc comparisons indicated that the number of discordant responses in the healthy participant group (0 ± 0) was significantly lower than for patients with either obsessive-compulsive disorder (2.222 ± 1.716; difference of means −2.222; P = 0.003) or schizophrenia (2.222 ± 1.563; difference of means −2.222; P = 0.003). No statistically significant difference was found between patients with obsessive-compulsive disorder and those with schizophrenia ( Figure 2 ).
Facial expression
Analysis of variance indicates that the "diagnosis" factor influenced the number of film-elicited emotions correctly expressed on the face (F[2.25] = 19.991; P , 0.001). FACS scores for healthy participants were significantly higher (7 ± 0.816) than in patients with obsessive-compulsive disorder (4.11 ± 1.453; difference of means −2.889; P , 0.001) or schizophrenia (3.33 ± 1.658; difference of means −3.667; P , 0.001). There was no statistically significant difference between patients with obsessivecompulsive disorder and those with schizophrenia. No significant difference was found between patients with obsessive-compulsive disorder and those with schizophrenia ( Figure 3 ).
Correlation between Y-BOCS, FACS, and post film questionnaire scores in patients with obsessive-compulsive disorder A statistically significant positive correlation was found between FACS score and concordant responses (r = 746; P = 0.021). Statistically significant negative correlations Table 4 ).
Correlation between PANSS, FACS, and post film questionnaire in patients with schizophrenia
The only signif icant correlation was found between PANSS total score and the negative PANSS subscale score (r = 0.787; P = 0.012). Among the others, the strongest positive correlations were found between discordant responses and the negative PANSS subscale score (r = 0.412) and the strongest negative correlation was found between FACS and PANSS total score (r = −0.369, Table 5 ).
Correlation between BPRS, FACS, and post film questionnaire
In the overall sample, there were significant positive correlations between BPRS total score and the BPRS affective flattening item (r = 0.697; P = 0.001) and between the number of concordant responses and FACS total score (r = 0.779; P , 0.001); significant negative correlations were found between FACS total score and BPRS total score (r = −0.469; P = 0.049) and between the BPRS affective flattening item and number of concordant responses (r = −0.487; P = 0.040).
In the obsessive-compulsive disorder group, significant positive correlations were found between BPRS total score and the BPRS affective flattening item (r = 0.707; P = 0.033) and between the number of concordant responses and FACS total score (r = 0.746; P = 0.021); significant negative correlations were found between the BPRS affective flattening item and FACS total score (r = −0.732; P = 0.025), between the number of concordant responses and number of discordant responses (r = −0.883; P = 0.002), and between FACS total score and number of discordant responses (r = −0.713; P = 0.031). No statistically significant correlations were found in the schizophrenia group (Table 6) . 
Discussion
To our knowledge, this is the first study investigating and comparing facial expressions in patients with schizophrenia and those with obsessive-compulsive disorder using the FACS system. As expected, the healthy controls showed more appropriate experience of emotion and facial expression than patients with schizophrenia and those with obsessive-compulsive disorder. It is known that patients with schizophrenia are impaired in their ability to discriminate and recognize emotions expressed by others, have difficulty in expressing their own emotional states, and show a marked deficiency in facial expression that may be correlated with length and type of pharmacological treatment. 13 Doop et al showed that worse social functioning is correlated with errors in recognition of emotional expressions on the face, and that patients with schizophrenia show general deficits in processing of emotional expressions which, 
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in turn, are associated with worse symptoms and reduced social functioning. 34 However, an emotion subjectively or objectively "experienced" by patients may be different from the emotion "recognized" by patients. For instance, a patient may recognize that a video is happy, but due to his/her affective psychopathology, experience sadness.
The results obtained by administration of the post film questionnaire showed that patients with schizophrenia and those with obsessive-compulsive disorder showed fewer concordant responses compared with healthy people (Figure 1) . It is interesting to note that there was no significant difference between the results for patients with schizophrenia and those with obsessive-compulsive disorder (Figure 1 ), indicating that patients with obsessive-compulsive disorder have an impairment almost identical to that in patients with schizophrenia with regard to experiencing emotions, even though this kind of impairment is usually considered a classical phenomenon related to schizophrenia and not to obsessivecompulsive disorder. 35, 36 This finding is strengthened by the scoring of facial activity in response to video clips eliciting emotion, ie, patients with obsessive-compulsive disorder showed mimic emotional responses very similar to those in patients with schizophrenia, and the scores for the two groups did not differ significantly ( Figure 3 ). These findings indicate that patients with schizophrenia and those with obsessive-compulsive disorder seem to suffer from similar impairments with regard to both experiencing and expressing emotions.
This common feature increases the number of characteristics shared between the two diseases. Obsessive-compulsive disorder and schizophrenia are, in fact, considered to be neurodevelopmental disorders with dysfunctional frontal submit your manuscript | www.dovepress.com Dovepress Dovepress subcortical circuitry. 37 A possible common neurodevelopmental origin is suggested by several lines of evidence: both obsessive-compulsive disorder and schizophrenia have a juvenile onset and chronic course; relevant neurological soft signs are present in both diseases; 38, 39 patients with obsessive-compulsive disorder and those with schizophrenia have more adverse perinatal experiences than healthy controls; 38, 40 obsessive-compulsive symptoms are clinically important phenomena in people with schizophrenia; and people with obsessive-compulsive disorder often experience psychosis. 41 In line with this theory, the impaired capacity to experience and express emotions may be seen as another chronic consequence of the same neurodevelopmental origin of the two diseases.
The hypothesized common neurodevelopmental origin of impaired expression and experience of emotions in obsessive-compulsive disorder and schizophrenia is also supported by the fact that this kind of impairment is less frequent and less relevant in psychiatric patients affected by diseases with a different presumed etiopathogenesis. For example, it is known that patients with bipolar disorder 42 or unipolar depression 16 are more accurate in recognizing emotions than patients with schizophrenia.
This study revealed an important correlation in the overall sample of patients between affective flattening, incongruent answers to a post film questionnaire, and low FACS scores (Table 6 ), leading to the idea that mimic expression is a behavioral indicator of affective flattening, 18 which is considered to be the most important negative symptom of schizophrenia, even if not pathognomic of the disease. Controversy surrounds the issue of whether second-generation antipsychotics are more effective than first-generation antipsychotics in the treatment of negative symptoms. However, it is undisputed that negative symptoms persist in many cases despite pharmacological treatment. [43] [44] [45] Negative symptoms are known to be strongly connected with neurogenesis, and thus present in both schizophrenia and obsessive-compulsive disorder: Flagstad et al 46 recently found that disruption of neurogenesis in the rat led to behavioral changes that mimic the negative symptoms of schizophrenia.
The results of this study also show a correlation between the severity of psychopathology and impaired ability to feel, express, and communicate emotions. A more severe psychopathological condition (measured on the BPRS scale) correlated with poorer facial expressiveness in the overall sample of patients, and more severe obsessive-compulsive symptoms (measured on the Y-BOCS scale) correlated with a minor number of concordant responses and with inappropriate mimic expression in patients with obsessivecompulsive disorder. These data partially confirm the results of previous studies 13 and highlight the fact that the FACS system could be used as a reliable semi-objective method to evaluate the clinical course in patients.
The small number of participants is a major limitation of this study and, for this reason, the results can only be considered preliminary. The choice to reduce the power of FACS to a binary number (expression prototype present or absent) makes it a less sensitive measure and, as such, different degrees of more refined and subtle facial movements could not be evaluated. However, this step was deemed necessary because it reduced the possibility of codification bias. Further studies are needed to assess further the differences and similarities between emotional responses in obsessive-compulsive disorder, schizophrenia, and other psychiatric disease.
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